MOTS-c vs. NAD+: How Their Research Roles Differ

MOTS-c and NAD+ are often grouped together because both appear in conversations about mitochondria, energy metabolism and aging. In the lab, though, they sit at different levels of cell biology. NAD+ is a coenzyme: part of the chemical machinery that moves electrons and fuels energy reactions. MOTS-c is a short peptide that acts as a signal, relaying information about metabolic stress between mitochondria, the nucleus and other tissues. One is closer to the engine, the other to the control system. Treating them as interchangeable “energy boosters” is the most common mistake in the material that ranks for this topic.

This guide explains what each compound is, what published research has examined, where the two overlap, and what a researcher should verify before buying either one. Everything here is educational and concerns laboratory research only.

TL;DR

• NAD+ is a redox coenzyme and enzyme substrate. It carries electrons for oxidative phosphorylation and feeds signaling enzymes such as sirtuins and PARPs.
• MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA. Research describes it as a signaling “mitokine” that acts mainly on skeletal muscle and metabolic gene expression.
• The two are complementary topics, not substitutes. One supplies a core metabolic molecule, the other studies how cells coordinate their response to stress.
• Neither is approved by the FDA for human use as a research-grade product. MOTS-c in particular has no completed clinical program, so independent lot-level testing matters.
• Peppy&Me supplies both for laboratory research use only, with third-party testing and lot-specific documentation.

What NAD+ does in the cell

Nicotinamide adenine dinucleotide (NAD+) is present in every living cell. A review of its biochemistry describes NAD+ and NADP+ as cofactors for most cellular oxidation and reduction reactions, cycling between oxidized forms and reduced forms (NADH and NADPH). In that role, NAD+ accepts electrons and, as NADH, hands them to the mitochondrial electron transport chain, which drives ATP production.

That is only half of the picture. A paper on cellular compartmentation explains that NAD+ is also a substrate for signaling enzymes that regulate protein post-translational modifications. Sirtuins and PARPs consume NAD+ as they work, which links the molecule to DNA repair, stress response and the study of aging. Because these enzymes use up NAD+, the pool has to be replenished constantly.

Two practical points shape how NAD+ is studied:

• Compartments matter. Mitochondrial NAD levels influence fuel selection, circadian rhythms and cell survival under stress, and researchers have examined how NAD reaches the mitochondria in mammalian cells. Total cellular NAD+ does not tell you what is happening inside the organelle.
• Form matters. NAD+ in its raw form is unstable and poorly absorbed, so much of the literature turns to precursors such as nicotinamide riboside or to delivery systems. One study of a liposomal formulation names low bioavailability and stability as the main obstacles for NAD+ formulations. The same line of work discusses reductive stress, a state in which NADH accumulates beyond available NAD+ and disrupts metabolic balance.

In short, NAD+ research is about a substrate: how much is available, where, and in what chemical form.

What MOTS-c does in the cell

MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) belongs to a small family of mitochondrial-derived peptides. Mitochondrial DNA is best known for encoding 37 genes, but a review of MOTS-c describes it as one of the peptides that also originate from mtDNA, alongside humanin. MOTS-c is 16 amino acids long.

Because it is made in the mitochondria and acts outside them, it is called a mitokine, or mitochondrial hormone. The most cited paper, in Nature Communications, reports that MOTS-c is exercise-induced and reports a 11.9-fold rise in skeletal muscle and a 1.6-fold rise in plasma in healthy volunteers after exercise. The same work links MOTS-c to muscle homeostasis and to age-dependent physical decline in animal models.

So MOTS-c research asks a different kind of question. Instead of “how much cofactor is present,” it asks “what message is the mitochondrion sending, and how do tissues respond?” For a closer look at that signaling pathway, see our explainer on MOTS-c retrograde signaling for researchers.

Side-by-side: how the research roles differ

A useful shorthand from the literature: NAD+ is the fuel and machinery, MOTS-c is the regulatory and communication layer. The shorthand is imperfect, since NAD+ also signals through sirtuins and PARPs, but it prevents the most common category error.

Where the two topics overlap

The overlap is real, which is why they are so often discussed together. Both are connected to mitochondrial function, metabolic stress and aging biology. A signaling peptide that shifts metabolic programs could, in principle, change how much NAD+ is consumed or regenerated, and an NAD+ pool that is depleted could change how cells respond to signals. Some of the stack-style content that ranks for this keyword claims that MOTS-c creates new mitochondria and NAD+ supplies what they need. Treat that framing as a hypothesis for a lab to test, not an established mechanism. The published literature cited above does not demonstrate a combined effect in humans.

For a researcher, the practical conclusion is to design experiments with separate variables. If both compounds are used in one protocol, the study should include arms for each alone, so any effect can be attributed.

The regulatory picture, in plain terms

MOTS-c is not approved by the FDA for human use. USADA’s guidance, last dated January 2024, notes that MOTS-c is a prohibited substance in sport, is sold under “research purposes only” labels, and lacks sufficient safety data. Reported, non-validated adverse effects from unauthorized use include increased heart rate, palpitations, insomnia and immune reactions. Anyone considering human use should talk to a physician. Our materials are not for that purpose.

Why do many interesting compounds remain in this research-only space? FDA approval requires a very large financial investment, multi-phase clinical trials and strong commercial backing. Compounds that occur naturally in the body, or that are difficult to patent, often attract less funding even when scientific interest continues. A peptide encoded in our own mitochondrial DNA fits that description: ongoing curiosity, limited sponsorship for large trials. That gap is the reason these molecules are studied preclinically and why the label “research use only” exists. If you want the background, read why some peptides are sold for research use only.

NAD+ is a different case, because it is a natural molecule found in food and used in many biochemical settings. Still, regulatory attention exists around sterile preparations: the FDA has reminded compounders to use ingredients suitable for sterile compounding after noting food-grade NAD+ solutions in use. The lesson for a laboratory is that the grade and sterility of the material are part of the experimental design.

What to verify before sourcing either compound

Because neither compound comes with the safety net of a fully regulated drug, the paperwork is the product. A researcher should check the following for every lot:

1. Identity and mass accuracy. Mass spectrometry should confirm the molecule is what the label says. For MOTS-c, the expected molecular weight should match the documented sequence.
2. Purity. HPLC purity results should be lot-specific, not a generic figure copied between batches.
3. Endotoxin testing. Endotoxin contamination can confound cell-based work and is not visible to the eye.
4. Sterility. Particularly relevant to NAD+ solutions and any material used in cell culture.
5. Heavy metals. Residues from synthesis or raw materials should be screened.
6. Traceability. A lot or batch number that can be followed from manufacturer to warehouse, with a certificate that matches the vial in hand.

We break these down further in five COA tests that matter for lab researchers.

Handling and measurement

Peptides and coenzymes both degrade if stored carelessly. Follow the storage instructions on the documentation for each lot, record reconstitution dates, and avoid repeated freeze-thaw cycles where the documentation advises against them. For accurate dilution math, the built-in dose calculator on our platform helps convert between concentration and volume, and the peptide glossary explains terms such as lyophilized, reconstitution and bacteriostatic water.

Research materials at Peppy&Me

Peppy&Me offers both compounds for laboratory research use only to authorized individuals and professionals aged 21 and over. Each product is third-party tested for purity, mass accuracy, endotoxins, sterility and heavy metals, with traceable lot and batch numbers and QR-based access to the certificate of analysis. Orders placed before 2 PM ship the same day within the U.S., and real-time support is available for order questions.

You can review the MOTS-c research material, the NAD+ research material, or browse the full research compounds catalog.

Our perspective

We see the same question from researchers again and again: “Which one should I pick?” Usually the better question is which variable the study is designed to test. If the work concerns redox balance, substrate availability or the enzymes that consume NAD+, NAD+ and its precursors are the natural focus. If it concerns mitochondrial signaling and how muscle and metabolic tissues respond to stress, MOTS-c is the more specific tool.

We also think the quality conversation gets less attention than it deserves. A peptide with limited human data and a coenzyme with formulation challenges both punish poor sourcing. That is why we publish batch documentation, test every lot through independent laboratories and make the certificate reachable from the vial. We would rather a researcher compare our certificate against the product in hand than take our word for it.

Finally, we keep our language careful. These are research materials, not treatments, and nothing we publish promises a result.

— Peppy&Me

For businesses: private label and partnership

Entrepreneurs who want to launch their own research-materials brand can use our backend fulfillment through the private label and dropshipping partnership program. The program carries a one-off onboarding fee of 500 $ and an active partnership fee of 99 $ per month. Partners remain responsible for compliance with research-use-only standards in their own marketing.

FAQ

Is MOTS-c the same as NAD+?

No. MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA that acts as a signaling molecule. NAD+ is a coenzyme that takes part directly in redox reactions and serves as a substrate for enzymes such as sirtuins and PARPs. Both relate to mitochondrial function, but they work at different levels.

What is the difference between NAD+ and peptides?

NAD+ is a dinucleotide, a small molecule built from nucleotides, not a chain of amino acids. Peptides such as MOTS-c are short amino acid chains, and many act as signals between cells. In research, that means different handling, different stability concerns and different quality tests.

Can NAD+ donate electrons for oxidative phosphorylation?

In its reduced form, NADH, yes. NAD+ accepts electrons during metabolism, and NADH then delivers them to the mitochondrial electron transport chain, which drives ATP production, as described in the biochemistry literature.

Are MOTS-c and NAD+ FDA-approved?

MOTS-c is not approved for human use, and USADA notes the lack of sufficient safety data. Peppy&Me sells both compounds strictly for laboratory research, not for human consumption or personal supplementation. Questions about health should go to a licensed physician.

Why does NAD+ research focus on precursors and liposomes?

Raw NAD+ has low stability and bioavailability, so researchers look at precursors such as nicotinamide riboside and at liposomal delivery to raise cellular levels, as one liposomal study discusses. These approaches also raise questions about reductive stress, which is why formulation is part of the experimental design.

Sources

• MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis, Nature Communications
• MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism, PMC
• Balancing NAD+ deficits with nicotinamide riboside, PMC
• Cellular Compartmentation and the Redox/Nonredox Functions of NAD+, PubMed
• Nicotinamide adenine dinucleotide is transported into mammalian mitochondria, PubMed
• A Liposomal Formulation Enhances the Anti-Senescence Properties of NAD+, MDPI
• What is the MOTS-c peptide? USADA
• FDA reminds compounders to use ingredients suitable for sterile compounding

Recommended

• 11.9 Fold Muscle Rise: MOTS-c Retrograde Signaling for Researchers
• Melanotan 2 Research Peptide 10mg | MT-II
• CJC-1295 No DAC Research Peptide | Modified GRF 1-29